Publications - Search Publications by Mayo Clinic Authors - Mayo Clinic Research

no_english_version

no_arabic_version

Search

Request an Appointment
Find a Doctor
Find a Job
Give Now

Log in to Patient Account
English

Twitter
Facebook
Pinterest
YouTube

English

Menu
Search

Search

All Mayo Clinic Topics

Care at Mayo Clinic
Health Information
Featured conditions
Brain tumor, breast cancer, colon cancer, congenital heart disease, heart arrhythmia. See more conditions.
For Medical Professionals
Research
College of Medicine and Science
Giving to Mayo Clinic

Search Results 211-220 of 227 for copd

Narrow your search

Year:

Results

Association of Phosphodiesterase-5 Inhibitor Treatment With Improved Survival in Pulmonary Hypertension Associated With COPD in the Pulmonary Vascular Research Institute GoDeep Meta-Registry.
1. Chan SY, Jose A, Tello K, Yogeswaran A, Majeed RW, Kiely DG, Lawrie A, Brittain E, Annis JS, Olschewski H, Kovacs G, Hassoun PM, Balasubramanian A, Konswa Z, Sweatt AJ, Zamanian RT, Wilkins MR, Howard L, Arvanitaki A, Giannakoulas G, Cajigas HR, Frantz R, Williams PG, Frauendorf M, Marquardt K, Antoine T, Fuenderich M, Richter M, Grimminger F, Ghofrani HA, Wilhelm J, Seeger W, Pulmonary Vascular Research Institute GoDeep Consortium.
2. Chest. 2025 Jan; 167 (1):224-240 Epub 2024 Sept 07
Long-term comparative immunogenicity of protein conjugate and free polysaccharide pneumococcal vaccines in chronic obstructive pulmonary disease.
1. Dransfield MT, Harnden S, Burton RL, Albert RK, Bailey WC, Casaburi R, Connett J, Cooper JA, Criner GJ, Curtis JL, Han MK, Make B, Marchetti N, Martinez FJ, McEvoy C, Nahm MH, Niewoehner DE, Porszasz J, Reilly J, Scanlon PD, Scharf SM, Sciurba FC, Washko GR, Woodruff PG, Lazarus SC, NIH COPD Clinical Research Network.
2. Clin Infect Dis. 2012 Sep; 55(5):e35-44. Epub 2012 May 31.
Heterogeneous burden of lung disease in smokers with borderline airflow obstruction.
1. Pirozzi CS, Gu T, Quibrera PM, Carretta EE, Han MK, Murray S, Cooper CB, Tashkin DP, Kleerup EC, Barjaktarevic I, Hoffman EA, Martinez CH, Christenson SA, Hansel NN, Graham Barr R, Bleecker ER, Ortega VE, Martinez FJ, Kanner RE, Paine R 3rd, NHLBI SubPopulations and InteRmediate Outcome Measures In COPD Study (SPIROMICS).
2. Respir Res. 2018 Nov 20; 19(1):223.
The Effects of Rare SERPINA1 Variants on Lung Function and Emphysema in SPIROMICS.
1. Ortega VE, Li X, O'Neal WK, Lackey L, Ampleford E, Hawkins GA, Grayeski PJ, Laederach A, Barjaktarevic I, Barr RG, Cooper C, Couper D, Han MK, Kanner RE, Kleerup EC, Martinez FJ, Paine R 3rd, Peters SP, Pirozzi C, Rennard SI, Woodruff PG, Hoffman EA, Meyers DA, Bleecker ER, NHLBI Subpopulations and Intermediate Outcomes Measures in COPD Study (SPIROMICS).
2. Am J Respir Crit Care Med. 2020 Mar 01; 201(5):540-554.
A genome-wide association study of bronchodilator response in participants of European and African ancestry from six independent cohorts.
1. Gereige JD, Xu H, Ortega VE, Cho MH, Liu M, Sakornsakolpat P, Silverman EK, Beaty TH, Miller BE, Bakke P, Gulsvik A, Hersh CP, Morrow JD, Ampleford EJ, Hawkins GA, Bleecker ER, Meyers DA, Peters SP, Celedon JC, Tantisira K, Li J, Dupuis J, O'Connor GT, International COPD Genetics Consortium.
2. ERJ Open Res. 2022 Apr; 8 (2) Epub 2022 June 27
Lung Structure and Risk of Sleep Apnea in SPIROMICS.
1. Koch AL, Shing TL, Namen A, Couper D, Smith B, Barr RG, Bhatt S, Putcha N, Baugh A, Saha AK, Ziedler M, Comellas A, Cooper CB, Barjaktarevic I, Bowler RP, Han MK, Kim V, Paine R 3rd, Kanner RE, Krishnan JA, Martinez FJ, Woodruff PG, Hansel NN, Hoffman EA, Peters SP, Ortega VE, SubPopulations and InteRmediate Outcome Measures in COPD Study (SPIROMICS) Investigators.
2. Chronic Obstr Pulm Dis. 2024 Jan 25; 11 (1):26-36
Music and 6-minute walk-distance-one step at a time: Commentary on "Rhythmic auditory stimulation increases 6-minute walk distance in individuals with COPD: A repeated measures study".
1. Heiderscheit A, Khan S, Khan B, Chlan LL.
2. Heart Lung 2020 Jul - Aug; 49 (4):435-436 Epub 2020 Feb 24
Music and six-minute walk-distance- one step at a time: Commentary on "Rhythmic auditory stimulation increases 6-minute walk distance in individuals with COPD: A repeated measures study".
1. Heiderscheit A, Khan S, Khan B, Chlan LL.
2. Heart Lung 2020 May - Jun; 49 (3):329-330 Epub 2020 Feb 29
Does Low FEV1 in Addition to Fixed Ratio and/or Lower Limit of Normal of FEV1/FVC Improve Prediction of Mortality in COPD? The NHANES-III-linked-mortality Cohort.
1. Odeyemi YE, Lewis O, Ngwa J, Dodd K, Gillum RF, Mehari A.
2. J Natl Med Assoc. 2018 Jul 28 Epub 2018 July 28
Use of Sodium-glucose cotransporter 2 (SGLT 2) inhibitor is associated with reduced emergency room visits and hospitalizations in patients with Chronic obstructive pulmonary disease (COPD) and type 2 Diabetes Mellitus.
1. Shanmugavel Geetha H, Teo YX, Ravichandran S, Perkit NR, Gogtay M, Lal A, Abraham GM, Trivedi N.
2. Respir Med. 2024 Nov-Dec; 234:107819 Epub 2024 Sept 24

Pagination Publications

Previous Page
Go to page 20
Go to page 21
Go to page 22
Go to page 23
Next Page

.

Mayo Clinic Footer

Request Appointment
Give Now
Contact Us
About Mayo Clinic
Employees
Site Map
About This Site

Legal Conditions and Terms

Any use of this site constitutes your agreement to the Terms and Conditions and Privacy Policy linked below.

Terms and Conditions
Privacy Policy
Notice of Privacy Practices
Notice of Nondiscrimination
Manage Cookies

Advertising

Mayo Clinic is a nonprofit organization and proceeds from Web advertising help support our mission. Mayo Clinic does not endorse any of the third party products and services advertised.

Advertising and sponsorship policy
Advertising and sponsorship opportunities

Reprint Permissions

A single copy of these materials may be reprinted for noncommercial personal use only. "Mayo," "Mayo Clinic," "MayoClinic.org," "Mayo Clinic Healthy Living," and the triple-shield Mayo Clinic logo are trademarks of Mayo Foundation for Medical Education and Research.

© 1998-2026